Pooled human immunoglobulin inhibits IL-4 but not IFN-γ or TNF-α secretion following in vitro stimulation of mononuclear cells with staphylococcal superantigen

Cytokine

Volumn 11, Issue 5, 1999, Pages 359-365

  Campbell, D E ^a   Georgiou, G M ^a   Kemp, A S ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cytokine; IFN ; IL 4; Immunoglobulin

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 4; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL;

STAPHYLOCOCCUS;

EID: 0032936557     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0435     Document Type: Article

References (34)

1. Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schoni M, Vest M, Wagner HP. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. i:1981;1228-1231.
2. Rosthoj S, Nielsen S, Pedersen FK. Randomized trial comparing intravenous immunoglobulin with methylprednisolone pulse therapy in acute idiopathic thrombocytopenic purpura. Danish I.T.P. Study Group. Acta Paediatr. 85:1996;910-915.
3. Toyoda M, Zhang XM, Petrosian A, Wachs K, Moudgil A, Jordan SC. Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin. Transplant Immunol. 2:1994;337-341.
4. Sullivan KM, Kopecky KJ, Jacom J, Fisher L, Buckner CD, Meyers JD, Counts GW, Bowden RA, Peterson FB, Witherspoon RP. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med. 323:1990;705-712.
5. Sussman GL, Pruzanski W. Treatment of inflammatory myopathy with intravenous gamma globulin. [Review]. Curr Opin Rheumatol. 7:1995;510-515.
6. Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest. 94:1994;1729-1735.
7. Aliu B, Bergdoll MS. Characterization of staphylococci from patients with toxic shock syndrome. J Clin Microbiol. 26:1988;2427-2428.
8. Crass BA, Bergdoll MS. Toxin involvement in toxic shock syndrome. J Infect Dis. 153:1986;918-926.
9. Evenson ML, Hinds MW, Bernstein RS, Bergdoll MS. Estimation of human dose of staphylococcal enterotoxin A from a large outbreak of staphylococcal food poisoning involving chocolate milk. Int J Food Microbiol. 7:1988;311-316.
10. Pereira JL, Salzberg SP, Bergdoll MS. Production of staphylococcal enterotoxin D in foods by low-enterotoxin-producing staphylococci. Int J Food Microbiol. 14:1991;19-25.
11. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 315:1986;341-347.
12. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Nat Acad Sci USA. 89:1992;4066-4070.
13. Leung DY. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin. [Review]. Clin Exp Immunol. 1:1996;49-54.
14. Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, Hanifin JM, Sampson HA. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest. 92:1993;1374-1380.
15. Campbell DE, Kemp AS. Proliferation and production of interferon-gamma and IL-4 in response to Staphylococcus aureus and Staphylococcal superantigen in childhood atopic dermatitis. Clin Exp Immunol. 107:1997;392-397.
16. Takei S, Arora YK, Walker SM. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest. 91:1993;602-607.
17. Nishi JI, Kanekura S, Takei S, Kitajima I, Nakajima T, Wahid MR, Masuda K, Yoshinaga M, Maruyama I, Miyata K. B cell epitope mapping of the bacterials superantigen staphylococcal enterotoxin B: the dominant epitope region recognized by intravenous IgG. J Immunol. 158:1997;247-254.
18. Leung D, Cotran R, Kurt-Jones E. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet. ii:1989;1298-1302.
19. Leung DY. Atopic dermatitis: immunobiology and treatment with immune modulators. [Review]. Clin Exp Immunol. 1:1997;25-30.
20. Gelfand EW, Landwehr LP, Esterl B, Mazer B. Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases. [Review]. Clin Exp Immunol. 1:1996;61-66.
21. Andersson J, Skansen SU, Sparrelid E, Andersson U. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Clin Exp Immunol. 1:1996;10-20.
22. Amran D, Renz H, Lack G, Bradley K, Gelfand EW. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin. Clin Immunol Immunop. 73:1994;180-186.
23. Andersson UG, Bjork L, Skansen SU, Andersson JP. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology. 79:1993;211-216.
24. Toungouz M, Denys C, Dupont E. Blockade of proliferation and tumor necrosis-alpha factor production occuring during mixed lymphocytic reaction by interferon-gamma specific natural antibodies contained in intravenous immunoglobulins. Transplantation. 62:1996;1292-1296.
25. Andersson JP, Andersson UG. Human intravenous immunoglobulin modulates monokine production in vitro. Immunology. 71:1990;372-376.
26. Banchereau J, Rousset F. Functions of interleukin-4 on human B lymphocytes. [Review]. Immunol Res. 10:1991;423-427.
27. Modiano J, Amran D, Lack G, Bradley K, Ball C, Domenico J, Gelfand E. Posttranscriptional regulation of T cell I1-2 production by human pooled immunoglobulin. Clin Immunol Immunopathol. 83:1997;77-85.
28. Montanaro A, Pirofsky B. Prolonged interval high-dose intravenous immunoglobulin in patients with primary deficiency states. Am J Med. 76:1984;67-78.
29. Jujo K, Renz H, Abe J, Gelfand EW, Leung DY. Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol. 90:1992;323-326.
30. Reinhold U, Wehrmann W, Kukel S, Kreysel HW. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol. 79:1990;374-379.
31. Tang M, Kemp A, Varigos G. IL4 and interferon-gamma production in children with atopic disease. Clin Exp Immunol. 92:1993;120-124.
32. Vercelli D, Jabara HH, Lauener RP, Geha RS. IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol. 144:1990;570-573.
33. Pene J, Chretien I, Rousset F, Briere F, Bonnefoy JY, de VJ. Modulation of IL-4 induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23). J Cell Biochem. 39:1989;253-264.
34. Konig B, Neuber K, Konig W. Responsiveness of peripheral blood mononuclear cells from normal and atopic donors to microbial superantigens. Int Arch Allergy Immun. 106:1995;124.